全文获取类型
收费全文 | 708篇 |
免费 | 72篇 |
出版年
2024年 | 3篇 |
2023年 | 3篇 |
2022年 | 12篇 |
2021年 | 19篇 |
2020年 | 8篇 |
2019年 | 12篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 38篇 |
2014年 | 30篇 |
2013年 | 32篇 |
2012年 | 51篇 |
2011年 | 47篇 |
2010年 | 29篇 |
2009年 | 35篇 |
2008年 | 41篇 |
2007年 | 37篇 |
2006年 | 40篇 |
2005年 | 31篇 |
2004年 | 19篇 |
2003年 | 12篇 |
2002年 | 21篇 |
2001年 | 19篇 |
2000年 | 8篇 |
1999年 | 18篇 |
1998年 | 5篇 |
1996年 | 5篇 |
1994年 | 3篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 10篇 |
1986年 | 5篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 3篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1970年 | 6篇 |
1969年 | 5篇 |
1967年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有780条查询结果,搜索用时 0 毫秒
91.
Jaclyn S. Long Yuko Fujiwara Joanne Edwards Claire L. Tannahill Gabor Tigyi Susan Pyne Nigel J. Pyne 《The Journal of biological chemistry》2010,285(46):35957-35966
We demonstrate here that the bioactive lipid sphingosine 1-phosphate (S1P) uses sphingosine 1-phosphate receptor 4 (S1P4) and human epidermal growth factor receptor 2 (HER2) to stimulate the extracellular signal regulated protein kinase 1/2 (ERK-1/2) pathway in MDA-MB-453 cells. This was based on several lines of evidence. First, the S1P stimulation of ERK-1/2 was abolished by JTE013, which we show here is an S1P2/4 antagonist and reduced by siRNA knockdown of S1P4. Second, the S1P-stimulated activation of ERK-1/2 was almost completely abolished by a HER2 inhibitor (ErbB2 inhibitor II) and reduced by siRNA knockdown of HER2 expression. Third, phyto-S1P, which is an S1P4 agonist, stimulated ERK-1/2 activation in an S1P4- and HER2-dependent manner. Fourth, FTY720 phosphate, which is an agonist at S1P1,3,4,5 but not S1P2 stimulated activation of ERK-1/2. Fifth, S1P stimulated the tyrosine phosphorylation of HER2, which was reduced by JTE013. HER2 which is an orphan receptor tyrosine kinase is the preferred dimerization partner of the EGF receptor. However, EGF-stimulated activation of ERK-1/2 was not affected by siRNA knockdown of HER2 or by ErbB2 (epidermal growth factor receptor 2 (or HER2)) inhibitor II in MDA-MB-453 cells. Moreover, S1P-stimulated activation of ERK-1/2 does not require an EGF receptor. Thus, S1P and EGF function in a mutually exclusive manner. In conclusion, the magnitude of the signaling gain on the ERK-1/2 pathway produced in response to S1P can be increased by HER2 in MDA-MB-453 cells. The linkage of S1P with an oncogene suggests that S1P and specifically S1P4 may have an important role in breast cancer progression. 相似文献
92.
93.
94.
95.
96.
97.
98.
99.
100.
Tammy Sobolik-Delmaire Dawn Katafiasz Sarah A. Keim My G. Mahoney 《Cell communication & adhesion》2007,14(2):99-109
Desmosomes are prominent cell-cell adhesive junctions found in a variety of epithelial tissues, including the oral epithelium. The transmembrane core of the desmosome is composed of the desmosomal cadherins that interact extracellularly to mediate cell-cell adhesion. The cytoplasmic domain of desmosomal cadherins interact with plaque proteins that in turn interact with the keratin intermediate filament cytoskeleton. Plakophilin 1 is a major desmosomal plaque component that functions to recruit intermediate filaments to sites of cell-cell contact via interactions with desmoplakin. Decreased assembly of desmosomes has been reported in several epithelial cancers. We examined plakophilin-1 expression in an esophageal squamous cell carcinoma tissue microarray and found that plakophilin-1 expression inversely correlates with tumor grade. In addition, we sought to investigate the effect of plakophilin-1 expression on desmosome assembly and cell motility in oral squamous cell carcinoma cell lines. Cell lines expressing altered levels of plakophilin-1 were generated and the ability of these cells to recruit desmoplakin to sites of cell-cell contact was examined. Our results show that decreased expression of plakophilin-1 results in decreased desmosome assembly and increased cell motility and invasion. These data lead us to propose that loss of plakophilin-1 expression during head and neck squamous cell carcinoma (HNSCC) progression may contribute to an invasive phenotype. 相似文献